The company is predicting slower growth in 2025 because of the impact of the Inflation Reduction Act redesign of Medicare Part D, in which three of the first 10 drugs up for price negotiation are J&J drugs
GLP-1 drugs have unexpectedly been found to potentially help with addiction disorders such as those associated with nicotine and other substances (Manalac, Dec 2024)
But it is no longer the whole job for many people living on a GLP-1
By simultaneously targeting appetite regulation, satiety, gastric motility, and central reward pathways, they produce clinically meaningful and sustained weight loss
Use of this information is at your own risk, and we are not liable for any outcomes resulting from its use.
Tea phenolics as prebiotics